Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene

L. Ferri, C. Guido, G. La Marca, S. Malvagia, C. Cavicchi, A. Fiumara, R. Barone, R. Parini, D. Antuzzi, C. Feliciani, A. Zampetti, Raffaele Manna, S. Giglio, C. M. Della Valle, X. Wu, K. J. Valenzano, E. R. Benjamin, M. A. Donati, R. Guerrini, Maurizio GenuardiA. Morrone

Risultato della ricerca: Contributo in rivistaArticolo in rivista

22 Citazioni (Scopus)


Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene. Fabry disease (FD) is an X-linked lysosomal storage disorder with a heterogeneous spectrum of clinical manifestations that are caused by the deficiency of α-galactosidase A (α-Gal-A) activity. Although useful for diagnosis in males, enzyme activity is not a reliable biochemical marker in heterozygous females due to random X-chromosome inactivation, thus rendering DNA sequencing of the α-Gal-A gene, alpha-galactosidase gene (GLA), the most reliable test for the confirmation of diagnosis in females. The spectrum of GLA mutations is highly heterogeneous. Many polymorphic GLA variants have been described, but it is unclear if haplotypes formed by combinations of such variants correlate with FD, thus complicating molecular diagnosis in females with normal α-Gal-A activity. We tested 67 female probands with clinical manifestations that may be associated with FD and 110 control males with normal α-Gal-A activity. Five different combinations of GLA polymorphic variants were identified in 14 of the 67 females, whereas clearcut pathogenetic alterations, p.Met51Ile and p.Met290Leu, were identified in two cases. The latter has not been reported so far, and both mutant forms were found to be responsive to the pharmacological chaperone deoxygalactonojirimycin (DGJ; migalastat hydrochloride). Analysis of the male control population, as well as male relatives of a suspected FD female proband, permitted the identification of seven different GLA gene haplotypes in strong linkage disequilibrium. The identification of haplotypes in control males provides evidence against their involvement in the development of FD phenotypic manifestations.
Lingua originaleEnglish
pagine (da-a)224-233
Numero di pagine10
RivistaClinical Genetics
Stato di pubblicazionePubblicato - 2012


  • Adult
  • Child
  • Fabry Disease
  • Female
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Mutation, Missense
  • Phenotype
  • alpha-Galactosidase


Entra nei temi di ricerca di 'Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene'. Insieme formano una fingerprint unica.

Cita questo